Michael E. Rockman

Michael E. Rockman

Auto-generated profile, based on publicly available information

Michael E. Rockman

Department of Medical Genetics and Molecular Biochemistry, Temple University Lewis Katz School of Medicine, Philadelphia, PA 1

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Cell Reports
Verified
Journal Article
Open access
Dhanendra TomarDhanendra Tomar
Dhanendra Tomar
ZDZhiwei Dong
Zhiwei Dong
SSSanthanam Shanmughapriya
Santhanam Shanmughapriya
DKDiana A. Koch
Diana A. Koch
TTToby Thomas
Toby Thomas
MMMuniswamy Madesh
Muniswamy Madesh
Mitochondrial Ca(2+) Uniporter (MCU)-dependent mitochondrial Ca(2+) uptake is the primary mechanism for increasing matrix Ca(2+) in most cell types. However, a limited understanding of the MCU complex assembly impedes the comprehension of the precise mechanisms underlying MCU activity. Here, we report that mouse cardiomyocytes and endothelial cells lacking MCU regulator 1 (MCUR1) have severely impaired [Ca(2+)]m uptake and IMCU current. MCUR1 binds to MCU and EMRE and function as a scaffold factor. Our protein binding analyses identified the minimal, highly conserved regions of coiled-coil domain of both MCU and MCUR1 that are necessary for heterooligomeric complex formation. Loss of MCUR1 perturbed MCU heterooligomeric complex and functions as a scaffold factor for the assembly of MCU complex. Vascular endothelial deletion of MCU and MCUR1 impaired mitochondrial bioenergetics, cell proliferation, and migration but elicited autophagy. These studies establish the existence of a MCU complex that assembles at the mitochondrial integral membrane and regulates Ca(2+)-dependent mitochondrial metabolism.

1 June 2020 in Journal of General Physiology
Verified
Journal Article
Open access
PDF file
MRMichael E. Rockman
Michael E. Rockman
AVAlexandre G. Vouga
Alexandre G. Vouga
BRBrad S. Rothberg
Brad S. Rothberg
Large-conductance Ca2+-activated K+ channels (BK channels) are activated by cytosolic calcium and depolarized membrane potential under physiological conditions. Thus, these channels control electrical excitability in neurons and smooth muscle by gating K+ efflux and hyperpolarizing the membrane in response to Ca2+ signaling. Altered BK channel function has been linked to epilepsy, dyskinesia, and other neurological deficits in humans, making these channels a key target for drug therapies. To gain insight into mechanisms underlying pharmacological modulation of BK channel gating, here we studied mechanisms underlying activation of BK channels by the biarylthiourea derivative, NS11021, which acts as a smooth muscle relaxant. We observe that increasing NS11021 shifts the half-maximal activation voltage for BK channels toward more hyperpolarized voltages, in both the presence and nominal absence of Ca2+, suggesting that NS11021 facilitates BK channel activation primarily by a mechanism that is distinct from Ca2+ activation. 30 µM NS11021 slows the time course of BK channel deactivation at −200 mV by ∼10-fold compared with 0 µM NS11021, while having little effect on the time course of activation. This action is most pronounced at negative voltages, at which the BK channel voltage sensors are at rest. Single-channel kinetic analysis further shows that 30 µM NS11021 increases open probability by 62-fold and increases mean open time from 0.15 to 0.52 ms in the nominal absence of Ca2+ at voltages less than −60 mV, conditions in which BK voltage sensors are largely in the resting state. We could therefore account for the major activating effects of NS11021 by a scheme in which the drug primarily shifts the pore-gate equilibrium toward the open state.

25 June 2015 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
ETElizabeth M. Troisi
Elizabeth M. Troisi
MRMichael E. Rockman
Michael E. Rockman
PNPhil P. Nguyen
Phil P. Nguyen
EOEmily Oliver
Emily Oliver
JHJustin Hines
Justin Hines
Summary: Yeast prions require a core set of chaperone proteins including Sis1, Hsp70 and Hsp104 to generate new amyloid templates for stable propagation, yet emerging studies indicate that propagation of some prions requires additional chaperone activities, demonstrating chaperone specificity beyond the common amyloid requirements. To comprehensively assess such prion‐specific requirements for the propagation of the [URE3] prion variant [URE3‐1], we screened 12 yeast cytosolic J‐proteins, and here we report a novel role for the J‐protein Swa2/Aux1. Swa2 is the sole yeast homolog of the mammalian protein auxilin, which, like Swa2, functions in vesicle‐mediated endocytosis by disassembling the structural lattice formed by the protein clathrin. We found that, in addition to Sis1, [URE3‐1] is specifically dependent upon Swa2, but not on any of the 11 other J‐proteins. Further, we show that [URE3‐1] propagation requires both a functional J‐domain and the tetratricopeptide repeat (TPR) domain, but surprisingly does not require Swa2‐clathrin binding. Because the J‐domain of Swa2 can be replaced with the J‐domains of other proteins, our data strongly suggest that prion‐chaperone specificity arises from the Swa2 TPR domain and supports a model where Swa2 acts through Hsp70, most likely to provide additional access points for Hsp104 to promote prion template generation.

6 August 2021 in Journal of General Physiology
Verified
Journal Article
Open access
PDF file
AVAlexandre G. Vouga
Alexandre G. Vouga
MRMichael E. Rockman
Michael E. Rockman
JYJiusheng Yan
Jiusheng Yan
MJMarlene A. Jacobson
Marlene A. Jacobson
BRBrad S. Rothberg
Brad S. Rothberg
Large-conductance Ca2+-activated K+ (BK) channels control a range of physiological functions, and their dysfunction is linked to human disease. We have found that the widely used drug loperamide (LOP) can inhibit activity of BK channels composed of either α-subunits (BKα channels) or α-subunits plus the auxiliary γ1-subunit (BKα/γ1 channels), and here we analyze the molecular mechanism of LOP action. LOP applied at the cytosolic side of the membrane rapidly and reversibly inhibited BK current, an effect that appeared as a decay in voltage-activated BK currents. The apparent affinity for LOP decreased with hyperpolarization in a manner consistent with LOP behaving as an inhibitor of open, activated channels. Increasing LOP concentration reduced the half-maximal activation voltage, consistent with relative stabilization of the LOP-inhibited open state. Single-channel recordings revealed that LOP did not reduce unitary BK channel current, but instead decreased BK channel open probability and mean open times. LOP elicited use-dependent inhibition, in which trains of brief depolarizing steps lead to accumulated reduction of BK current, whereas single brief depolarizing steps do not. The principal effects of LOP on BK channel gating are described by a mechanism in which LOP acts as a state-dependent pore blocker. Our results suggest that therapeutic doses of LOP may act in part by inhibiting K+ efflux through intestinal BK channels.

1 January 2017 in Ornithology
Verified
Journal Article
Closed access
MBMichael W. Butler
Michael W. Butler
SBSamantha C. Bociulis
Samantha C. Bociulis
ALAaron R. Little
Aaron R. Little
JMJennifer A. Minnick
Jennifer A. Minnick
NRNathan J. Ritter
Nathan J. Ritter
JHJustin Hines
Justin Hines
Avian eggshells exhibit a variety of colors and patterns whose functions include camouflage, detection of brood parasites, and facilitation of embryonic development. In addition, eggshell coloration, specifically blue-green coloration, may signal a female's quality to her mate. This signaling hypothesis relies on the assumption that biliverdin, the pigment responsible for blue-green eggshell coloration, is an indicator of female quality. Biliverdin is the product of heme degradation and has antioxidant and immunomodulating properties, supporting the possibility that if only a limited amount of biliverdin can be produced, deposition of this pigment into eggshells may be costly to females. However, these putative physiological functions of biliverdin were established by mammal-based studies, even though mammals produce an enzyme—biliverdin reductase—that readily converts biliverdin into bilirubin. Thus, the assumed physiological properties of biliverdin stem from data based on the end-product bilirubin, rather than biliverdin itself. Therefore, to assess the physiological role of biliverdin in birds, it is essential to quantify biliverdin in nonmammalian tissues in a manner that is repeatable, uses relatively accessible laboratory equipment, and is accurate at very low concentrations. Here, we develop a protocol that quantifies biliverdin in avian liver and spleen, the 2 organs that are predominately responsible for biliverdin production. Biliverdin concentration in both tissues was highly repeatable (R = 0.99) and could be accurately quantified at concentrations as low as 3.1 nM, which was less than the concentration of biliverdin in every sample that we tested. Recovery was calculated based on additions of biliverdin standard to each sample, and recoveries typically ranged from 60% to 95% for all 16 species (13 families, 4 orders) of birds in this study. Use of this assay will allow for the quantification of biliverdin concentration in a tissue-specific manner, which will be critical in determining the type and extent of biliverdin's physiological role. Las cáscaras de los huevos de las aves exhiben una variedad de colores y patrones cuyas funciones incluyen camuflaje, detección de parásitos de la muda y facilitación del desarrollo embrionario. Adicionalmente, la coloración de la cáscara del huevo, específicamente la coloración azul-verdosa, puede representar una señal de la calidad de la hembra hacia su consorte. Esta hipótesis de señalización se basa en la suposición de que la biliverdina, el pigmento responsable de la coloración azul-verdosa de la cáscara del huevo, es un indicador de la calidad de la hembra. La biliverdina es el producto de la degradación de la hemoglobina y tiene propiedades antioxidantes e inmuno-moduladoras, apoyando la idea de que si solo puede producirse una pequeña cantidad de biliverdina, la deposición de este pigmento en la cáscara del huevo podría ser costosa para las hembras. Sin embargo, estas supuestas funciones fisiológicas de la biliverdina fueron establecidas en estudios basados en mamíferos, aunque los mamíferos producen una enzima – biliverdina reductasa– que convierte fácilmente la biliverdina en bilirrubina. De este modo, las propiedades fisiológicas asumidas de la biliverdina surgen de datos basados del producto final bilirrubina, más que de la biliverdina en sí mismo. Por ende, para evaluar el rol fisiológico de la biliverdina en las aves, es esencial cuantificar la biliverdina en tejidos no mamíferos de un modo repetible, usando equipamiento de laboratorio relativamente accesible, y preciso a muy bajas concentraciones. En este trabajo, desarrollamos un protocolo que cuantifica la biliverdina en el hígado y el bazo de las aves, los dos órganos que son predominantemente responsables de la producción de biliverdina. La concentración de biliverdina en ambos tejidos fue altamente repetible (R = 0.99) y pudo ser cuantificada con precisión a concentraciones tan bajas como 3.1 nM, lo que es menos que la concentración de biliverdina en cada muestra que evaluamos. La recuperación se calculó en base a la sumatoria estándar de biliverdina para cada muestra y las recuperaciones típicamente fluctuaron entre 60% y 95% para las 16 especies (13 familias, 4 órdenes) de aves de este estudio. El uso de este ensayo permitirá cuantificar la concentración de biliverdina de un modo específico para cada tejido, lo que será crítico para determinar el tipo y el alcance del rol fisiológico de la biliverdina. Palabras clave: biliverdina, coloración de la cáscara del huevo, fisiología oxidativa, función inmune, protoporfirina